Treace Medical Concepts Investors Alerted to Class Action Lawsuit and Important Deadline
Investors Take Note: Treace Medical Concepts Faces Class Action Lawsuit
On May 29, 2025, The Gross Law Firm announced to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) about a significant class action lawsuit that has been initiated. This notice is particularly relevant to shareholders who purchased TMCI shares during the designated class period from May 8, 2023, to May 7, 2024. The firm encourages these investors to get in touch for potential lead plaintiff appointments, although it is important to note that participating in recovery does not require being appointed as lead plaintiff.
Allegations Against Treace Medical Concepts
The crux of the allegations involves statements made by the defendants during the class period, which purportedly contained material misrepresentations or omissions. Specifically, the complaint contends that Treace Medical made materially false claims regarding the demand and utilization of their flagship product, the 3D bunion correction system commonly known as